WallStreetZenWallStreetZen

NASDAQ: NGNE
Neurogene Inc Stock Ownership - Who owns Neurogene?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neurogene Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christine Mikail CvijicPresident and CFO2026-05-064,800$30.07
$144.35kSell
Christine Mikail CvijicPresident and CFO2026-05-064,800$32.44
$155.69kSell
Rachel McMinnChief Executive Officer2026-03-263,352$22.08
$74.00kSell
Christine Mikail CvijicPresident and CFO2026-03-262,558$21.63
$55.32kSell
Julie JordanChief Medical Officer2026-03-26828$21.89
$18.13kSell
Stuart CobbChief Scientific Officer2026-03-133,991$20.41
$81.46kSell
Christine Mikail CvijicPresident and CFO2026-03-13263$22.02
$5.79kSell
Stuart CobbChief Scientific Officer2026-03-132,658$21.34
$56.72kSell
Stuart CobbChief Scientific Officer2026-03-13148$22.08
$3.27kSell
Christine Mikail CvijicPresident and CFO2026-03-132,387$20.42
$48.75kSell

1 of 2

NGNE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NGNE insiders and whales buy or sell their stock.

NGNE Shareholders

What type of owners hold Neurogene Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC24.47%3,866,579$106.33MInsider
Jonathan G. Drachman14.55%2,298,686$63.21MInsider
Gary Bridger12.17%1,922,775$52.88MInsider
Samsara Biocapital LLC10.87%1,717,127$47.22MInstitution
Samsara Biocapital GP LLC10.56%1,668,357$45.88MInsider
Ventures West 8 Limited Partnership9.77%1,543,989$42.46MInsider
Redmile Group LLC9.24%1,459,599$40.14MInstitution
Johnson Johnson9.13%1,442,094$39.66MInsider
Casdin Capital LLC8.99%1,420,361$39.06MInstitution
Rtw Investments LP8.62%1,362,456$37.47MInstitution

1 of 3

NGNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NGNE48.66%51.34%Net SellingNet Selling
SGMT21.82%35.89%Net Selling
IPSC76.16%23.50%Net SellingNet Selling
UPB71.16%28.84%Net SellingNet Selling
ASMB51.34%48.66%Net BuyingNet Buying
View Top Biotech Stocks

Neurogene Stock Ownership FAQ

Who owns Neurogene?

Neurogene (NASDAQ: NGNE) is owned by 107.39% institutional shareholders, 113.31% Neurogene insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Neurogene shareholder, owning 3.87M shares representing 24.47% of the company. Redmile Group LLC's Neurogene shares are currently valued at $109.58M.

If you're new to stock investing, here's how to buy Neurogene stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.